SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (19053)2/24/1999 9:16:00 AM
From: DaiS  Respond to of 23519
 
BigK,

Thanks for this information. I was particularly interested in the article on gene therapy - I will try to get it. Dr Melman is a colleague and collaborator of Dr Christ.

DaiS



To: BigKNY3 who wrote (19053)2/24/1999 9:21:00 AM
From: BigKNY3  Read Replies (1) | Respond to of 23519
 
Houstonpress.com examined Zonagen and the development of Vasomax on 8/20/98 houston-press.com

BigKNY3



To: BigKNY3 who wrote (19053)2/24/1999 2:03:00 PM
From: VLAD  Respond to of 23519
 
<<The report has drawn a scathing rebuttal from the drug industry>>

What did you expect? A glowing reception to a report that exposes the fact that big pharma money controls the politicians who control the FDA? Get real!



To: BigKNY3 who wrote (19053)2/24/1999 4:00:00 PM
From: DAVID  Read Replies (1) | Respond to of 23519
 
Vlad and BigK,

I always appreciate the information presented. Keep it up.

DAVID


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News